Trump Names India, Pakistan, 21 Other Countries As Major Drug Transits
US President Donald Trump has named 23 countries as the major drug transit or major illicit drug-producing countries in a 'Presidential Determination' submitted to Congress.
- Date & Time:
- |
- Views: 28
- |
- From: India News Bull
President Donald Trump has identified 23 countries as major drug transit or illicit drug-producing nations in a 'Presidential Determination' document presented to Congress.
Among the designated countries are China, Afghanistan, India, and Pakistan. The US President has emphasized his dedication to overcoming the challenges posed by illegal drug trade within the United States.
The comprehensive list also includes The Bahamas, Belize, Bolivia, Burma, Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Laos, Mexico, Nicaragua, Panama, Peru, and Venezuela.
In his 'Presidential Determination,' President Trump specifically designated Afghanistan, Bolivia, Burma, Colombia, and Venezuela as nations that have "failed demonstrably" over the past 12 months to fulfill their obligations under international counternarcotics agreements and to enhance their counternarcotics efforts.
"A country's presence on the foregoing list is not necessarily a reflection of its government's counterdrug efforts or level of cooperation with the United States," the Presidential Determination stated.
The document explained that countries appear on the list due to "the combination of geographic, commercial, and economic factors that allow drugs or precursor chemicals to be transited or produced, even if a government has engaged in robust and diligent narcotics control and law enforcement measures."
In a related development, the Narcotics Control Bureau (NCB) recently collaborated with other agencies to dismantle a sophisticated transnational drug trafficking network that utilized encrypted digital platforms, drop shipping models, and cryptocurrency for smuggling controlled medicines across four continents.
The operation began with a routine vehicle inspection near Bengali Market in New Delhi, which led to the discovery of an elaborate criminal organization operating throughout India, the United States of America, Australia, and Europe. This case highlights both the global reach of illicit pharmaceutical networks and NCB's ability to coordinate international enforcement operations.
The US Embassy in India expressed gratitude to NCB for their actions against the illegal drug operation.
"Thanks to NCB and Indian authorities for helping protect Americans against illegal drugs and saving American lives!" the embassy stated.